Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
05/07/2009 | WO2006047593A3 Method of potentiating inflammatory and immune modulation for cell and drug therapy |
05/07/2009 | WO2006045105A3 Generation and differentiation of adult stem cell lines |
05/07/2009 | WO2006025060A3 Salt responsive genes useful for generating salt resistant transgenic plants |
05/07/2009 | US20090119805 Nuleic acid constructs and methods for producing altered seed oil compositions |
05/07/2009 | US20090119799 nucleic acid molecule encoding an isolated polypeptide having fungicidal activity against Colletotrichum, Diplodia, or Fusarium |
05/07/2009 | US20090119798 Barley Row Type Gene and Use Thereof |
05/07/2009 | US20090119797 Gro-1 herbicide resistance gene and methods for its use |
05/07/2009 | US20090119796 Modification of plant lignin content |
05/07/2009 | US20090119795 Delta-9-Elongases and their Use in Making Polyunsaturated Fatty Acids |
05/07/2009 | US20090119793 Plant Defense Signal Peptides |
05/07/2009 | US20090119792 Tomato variety ex01419137 |
05/07/2009 | US20090119791 Tobacco cultivar 'aob 175' |
05/07/2009 | US20090119790 Tobacco cultivar 'aob 174' |
05/07/2009 | US20090119789 Tobacco cultivar 'aob 176' |
05/07/2009 | US20090119788 Tobacco cultivar 'aob 171' |
05/07/2009 | US20090118474 Method and composition for crystallizing G protein-coupled receptors |
05/07/2009 | US20090118469 High-Affinity Antagonists of ELR-CXC Chemokines |
05/07/2009 | US20090118468 Immunotherapy of prostate, including hormone-refractory prostate cancer (HRPC), and breast cancer; vaccines |
05/07/2009 | US20090118377 Apogossypolone and the uses thereof |
05/07/2009 | US20090118362 Chemotherapeutic agents for inhibition of protein translation |
05/07/2009 | US20090118306 Novel use of liver X receptor agonists |
05/07/2009 | US20090118290 Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity |
05/07/2009 | US20090118244 Benzodiazepinone compounds useful in the treatment of skin conditions |
05/07/2009 | US20090118219 Flea gaba receptor subunit nucleic acid molecules |
05/07/2009 | US20090118212 Methods for producing and using in vivo pseudotyped retroviruses |
05/07/2009 | US20090118210 Epididymal lipocalin gene and uses thereof |
05/07/2009 | US20090118209 Use of the slug gene as a genetic marker in functions mediated by SCF (stem cell factor) and applications |
05/07/2009 | US20090118206 Rna interference for the treatment of gain-of-function disorders |
05/07/2009 | US20090118187 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
05/07/2009 | US20090118185 Recombinant factor viii having reduced inactivation by activated protein c |
05/07/2009 | US20090118184 Recombinant factor viii having increased stability |
05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
05/07/2009 | US20090118166 Conditioned Decellularized Native Tissues for Tissue Restoration |
05/07/2009 | US20090118130 Structure-activity relationships |
05/07/2009 | US20090117657 Preparation For Transferring Nucleic Acid Into Cell |
05/07/2009 | US20090117656 Stimuli-responsive degradable gel |
05/07/2009 | US20090117655 Culture Matrix for Forming a Cell Spheroid, and Method of Culturing the Same |
05/07/2009 | US20090117654 Medium for culturing hematopoietic cells and a method of culturing hematopoietic cells |
05/07/2009 | US20090117653 Method and apparatus for evaluating therapeutics on cancer stem cells |
05/07/2009 | US20090117652 in vitro use of granulocyte chemotactic protein-2 (CXCL6) to promote cartilage (and underlying bone) formation e.g. in the repair of cartilage or osteochondral defects; osteoarthritis |
05/07/2009 | US20090117651 Nucleoside compounds and methods of use thereof |
05/07/2009 | US20090117650 Modified green fluorescent proteins and methods for using same |
05/07/2009 | US20090117641 Mutated Abl Kinase Domains |
05/07/2009 | US20090117639 Neural Progenitor Cell Populations |
05/07/2009 | US20090117627 Process for preparing enantiomerically enriched amines |
05/07/2009 | US20090117618 Expression system for preparing IL-15/FC fusion protein and its use |
05/07/2009 | US20090117615 Recombinant mammal cells, method of producing thereof, and method of producing proteins of interest |
05/07/2009 | US20090117614 degrading mannans and polysaccharides in plant material thus providing a means to recover soluble sugars from these biopolymers |
05/07/2009 | US20090117610 Methods and Compositions for Identifying a Cell Phenotype |
05/07/2009 | US20090117593 T. Cruzi-derived neurotrophic agents and methods of use therefor |
05/07/2009 | US20090117590 Human calcium sensitive potassium channel beta3 subunit proteins, encoding nucleic acid and uses thereof |
05/07/2009 | US20090117585 Anti-fungal screening method |
05/07/2009 | US20090117581 in vitro comprising preparing a cell culture comprising dendritic cells primed with an antigen, then adding syngeneic and allogeneic lymphocytes to the cell culture and measuring the lymphocyte response to the antigen and comparing the response control culture in which the antigen was not used |
05/07/2009 | US20090117577 Methods to identify compounds useful for tumor sensitization to dna damage |
05/07/2009 | US20090117572 Modified cells comprising clostridial toxin substrate for use in diagnosing grampositive bacterial infection; screening for neuroparalytic and botulin syndromes |
05/07/2009 | US20090117564 Estrogen receptor genes and utilization thereof |
05/07/2009 | US20090117563 Identification of TRPML3 (MCOLN3) as a Salty Taste Receptor and Use in Assays for Identifying Taste (Salty) Modulators and/or Therapeutics that Modulate Sodium Transport, Absorption or Excretion and/or Aldosterone and/or Vasopressin Production or Release |
05/07/2009 | US20090117547 NOVEL HAPLOTYPE OF HUMAN T2R RECEPTOR hT2R50 AND ITS USE IN ASSAYS FOR IDENTIFYING HUMAN BITTER TASTE MODULATORS |
05/07/2009 | US20090117545 Glycine riboswitches, methods for their use, and compositions for use with glycine riboswitches Cross-Reference to Related Applications |
05/07/2009 | US20090117543 Methods and compositions for inducing sirtuins |
05/07/2009 | US20090117539 DNA sequences for gene suppression |
05/07/2009 | US20090117538 Methods for Obtaining Gene Tags |
05/07/2009 | US20090117175 Hemostatic compositions and therapeutic regimens |
05/07/2009 | US20090117155 Treatment of hiv-1 by modulation of vpr activation of the m-csf promoter |
05/07/2009 | US20090117153 Disulfide Trap MHC Class I Molecules and Uses Therefor |
05/07/2009 | US20090117134 Truncated EGF Receptor |
05/07/2009 | US20090117133 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS |
05/07/2009 | US20090117126 Neutralising Antibody Molecules Having Specificity for Human IL-17 |
05/07/2009 | US20090117124 Anti-IgE antibodies |
05/07/2009 | US20090117121 Pseudomonas Aeruginosa Outer Membrane Protein PA0427 |
05/07/2009 | US20090117118 Antibodies specific for sclerostin and methods for increasing bone mineralization |
05/07/2009 | US20090117117 Targeting abcb5 for cancer therapy |
05/07/2009 | US20090117116 Immunogenic peptides and methods of use for treating and preventing cancer |
05/07/2009 | US20090117114 IL-17 homologous polypeptides and therapeutic uses thereof |
05/07/2009 | US20090117104 Glucagon-like peptide-2 (GLP-2); treating inflammatory ileus |
05/07/2009 | US20090117096 Methods and compositions for inhibition of metastasis |
05/07/2009 | US20090117095 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia |
05/07/2009 | US20090117086 Preparation of replicating macrophages and use in diagnosis and therapy |
05/07/2009 | US20090117085 Mntf differentiation and growth of stem cells |
05/07/2009 | US20090117084 Bacteriophage and prophage proteins in cancer gene therapy |
05/07/2009 | US20090117057 Grape Polyphenolics for Platelet and Bacterial Control |
05/07/2009 | US20090117043 Antibodies That Specifically Bind to Neurokinin B |
05/07/2009 | US20090117036 Antibodies against gpr64 and uses thereof |
05/07/2009 | US20090117032 Imaging Agents for Early Detection and Monitoring of Cardiovascular Plaque |
05/07/2009 | US20090117031 Methods for Treating Glioma |
05/07/2009 | CA2714777A1 Methods for co-culturing cord blood derived cells with menstrual stem cells |
05/07/2009 | CA2703825A1 New antibodies specific of the .beta.-amyloid peptides and their uses as diagnostic agents or drugs |
05/06/2009 | EP2056111A1 Methods and compositions for regulating protein-protein interactions |
05/06/2009 | EP2055779A2 Auxin transport proteins |
05/06/2009 | EP2055772A1 Method for inhibiting the development of teratoma |
05/06/2009 | EP2055713A1 Peptide purification by means of metal ion affinity chromatography |
05/06/2009 | EP2055308A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
05/06/2009 | EP2054512A2 Pullulanase variants with increased productivity |
05/06/2009 | EP2054508A2 Tumor suppression using placental stem cells |
05/06/2009 | EP2054507A1 Method of production of transgenic avian using embryonic stem cells |
05/06/2009 | EP2054506A1 Mesenchymal stem cell conditioned medium |
05/06/2009 | EP2054504A2 Retinoid compounds and their use |
05/06/2009 | EP2054444A2 Antibodies to erbb2 |
05/06/2009 | EP2054437A2 Albumin-insulin fusion proteins |
05/06/2009 | EP2054077A2 Polypeptide derivatives of parathyroid hormone (pth) |